A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
Clinical trial NCT02978443 · TERMINATED
Trial details
- NCT number
- NCT02978443
- Sponsor
- Georgetown University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2020-07-28
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.